IBSRELA: payments to doctors
Payments that named IBSRELA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5.4M
- Providers
- 27,522
- Transactions
- 135,074
- Average per transaction
- $40
The per-transaction average — $40 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 27,522 providers the average total is $195, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Ardelyx, Inc. | $5,364,373 | 100.0% |